Assessment of Bronchial Asthma Among Patients Attending Sohag University Hospital
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- percent of controlled bronchial asthma patients
研究概览
简要总结
Asthma is a significant public health threat, affecting more than 300 million individuals globally. Asthma is classified as a non-communicable disease and leads to reduced quality of life, poor physical functioning and reduced emotional well-being. The impact of this disease can be widespread and extends beyond the person living with the disease, affecting the lives of their family members, carers, communities and the health care system (1).
Asthma is a variable chronic respiratory condition. It is characterized by symptoms of wheeze, cough, chest tightness, dyspnea and backed by variable airflow limitation, airway inflammation and airway hyper-responsiveness (AHR). The severity of asthma varies considerably, both between individuals and within individuals over time. Some people may have intermittent asthma and others may experience severe, potentially life-threatening disease (2, 3,4).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •bronchial asthma patients aged more than 18 years, both sexes are included
排除标准
- •children ,patients who are unable to do spiromerty or contrindecated
研究组 & 干预措施
group A,
group A (controlled bronchial asthma patients)
干预措施: corticosteroids (Drug)
group B
group B(uncontrolled bronchial asthma patients)
干预措施: corticosteroids (Drug)
结局指标
主要结局
percent of controlled bronchial asthma patients
时间窗: 12 months
to detect percent of controlled patients
次要结局
未报告次要终点
研究者
Doha Mohamed Ismail
Resident of chest department, Sohag university hospital
Sohag University